Wealthfront Advisers LLC Increases Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Wealthfront Advisers LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4,594.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 569,812 shares of the medical device company’s stock after buying an additional 557,673 shares during the quarter. Wealthfront Advisers LLC’s holdings in Cooper Companies were worth $52,383,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. raised its stake in shares of Cooper Companies by 6.6% in the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Covestor Ltd raised its stake in shares of Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the third quarter valued at $25,000. Catalytic Wealth RIA LLC purchased a new stake in Cooper Companies during the third quarter valued at $318,000. Finally, Venturi Wealth Management LLC increased its position in Cooper Companies by 40.4% during the third quarter. Venturi Wealth Management LLC now owns 4,699 shares of the medical device company’s stock valued at $518,000 after acquiring an additional 1,351 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ COO opened at $79.89 on Tuesday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $79.74 and a 52-week high of $112.38. The business’s 50-day moving average price is $92.14 and its 200 day moving average price is $99.34. The firm has a market cap of $15.94 billion, a P/E ratio of 40.97, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently commented on COO. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday. Wells Fargo & Company boosted their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $111.89.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.